Patricia Rivera

Dr. Patricia Rivera

orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 May 2011 in British Journal of Pharmacology
Verified
Journal Article
Open access
PDF file
ACA Crespillo
A Crespillo
MAM Alonso
M Alonso
MVM Vida
M Vida
FPFj Pavón
Fj Pavón
ASAntonia Serrano
Antonia Serrano
FFFr de Fonseca
Fr de Fonseca
BACKGROUND AND PURPOSE The lack of safe and effective treatments for obesity has increased interest in natural products that may serve as alternative therapies. From this perspective, we have analysed the effects of daidzein, one of the main soy isoflavones, on diet‐induced obesity in rats.EXPERIMENTAL APPROACH Rats made obese after exposure to a very (60%) high fat‐content diet were treated with daidzein (50 mg·kg−1) for 14 days. The dose was selected on the basis of the acute effects of this isoflavone on a feeding test. After 14 days, animals were killed and plasma, white and brown adipose tissue, muscle and liver studied for the levels and expression of metabolites, proteins and genes relevant to lipid metabolism.KEY RESULTS A single treatment (acute) with daidzein dose‐dependently reduced food intake. Chronic treatment (daily for 14 days) reduced weight gain and fat content in liver, accompanied by high leptin and low adiponectin levels in plasma. While skeletal muscle was weakly affected by treatment, both adipose tissue and liver displayed marked changes after treatment with daidzein, affecting transcription factors and lipogenic enzymes, particularly stearoyl coenzyme A desaturase 1, a pivotal enzyme in obesity. Expression of uncoupling protein 1, an important enzyme for thermogenesis, was increased in brown adipose tissue after daidzein treatment.CONCLUSIONS AND IMPLICATIONS These results support the use of isoflavones in diet‐induced obesity, especially when hepatic steatosis is present and open a new field of use for these natural products.

5 December 2011 in Alcohol, Clinical and Experimental Research
Verified
Journal Article
Closed access
PDF file
ASAntonia Serrano
Antonia Serrano
PRPatricia Rivera
Patricia Rivera
Francisco Javier Pavón MorónFrancisco Javier Pavón Morón
Francisco Javier Pavón Morón
JDJuan Decara
Juan Decara
Juan SuárezJuan Suárez
Juan Suárez
LPLoren H. Parsons
Loren H. Parsons

31 May 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
PRPatricia Rivera
Patricia Rivera
MPMargarita Pérez-Martín
Margarita Pérez-Martín
Francisco Javier Pavón MorónFrancisco Javier Pavón Morón
Francisco Javier Pavón Morón
ASAntonia Serrano
Antonia Serrano
ACAna Crespillo
Ana Crespillo
Juan SuárezJuan Suárez
Juan Suárez
Soy extracts have been claimed to be neuroprotective against brain insults, an effect related to the estrogenic properties of isoflavones. However, the effects of individual isoflavones on obesity-induced disruption of adult neurogenesis have not yet been analyzed. In the present study we explore the effects of pharmacological administration of daidzein, a main soy isoflavone, in cell proliferation, cell apoptosis and gliosis in the adult hippocampus of animals exposed to a very high-fat diet. Rats made obese after 12-week exposure to a standard or high-fat (HFD, 60%) diets were treated with daidzein (50 mg kg−1) for 13 days. Then, plasma levels of metabolites and metabolic hormones, cell proliferation in the subgranular zone of the dentate gyrus (SGZ), and immunohistochemical markers of hippocampal cell apoptosis (caspase-3), gliosis (GFAP and Iba-1), food reward factor FosB and estrogen receptor alpha (ERα) were analyzed. Treatment with daidzein reduced food/caloric intake and body weight gain in obese rats. This was associated with glucose tolerance, low levels of HDL-cholesterol, insulin, adiponectin and testosterone, and high levels of leptin and 17β-estradiol. Daidzein increased the number of phospho-histone H3 and 5-bromo-2-deoxyuridine (BrdU)-ir cells detected in the SGZ of standard diet and HFD-fed rats. Daidzein reversed the HFD-associated enhanced immunohistochemical expression of caspase-3, FosB, GFAP, Iba-1 and ERα in the hippocampus, being more prominent in the dentate gyrus. These results suggest that pharmacological treatment with isoflavones regulates metabolic alterations associated with enhancement of cell proliferation and reduction of apoptosis and gliosis in response to high-fat diet.

1 January 2013 in Disease Models & Mechanisms
Verified
Journal Article
Open access
PDF file
Juan SuárezJuan Suárez
Juan Suárez
PRPatricia Rivera
Patricia Rivera
SASergio Arrabal
Sergio Arrabal
ACAna Crespillo
Ana Crespillo
ASAntonia Serrano
Antonia Serrano
FFFernando Rodríguez de Fonseca
Fernando Rodríguez de Fonseca
β-adrenergic receptor activation promotes brown adipose tissue (BAT) β-oxidation and thermogenesis by burning fatty acids during uncoupling respiration. Oleoylethanolamide (OEA) can inhibit feeding and stimulate lipolysis by activating peroxisome proliferator-activating receptor-α (PPARα) in white adipose tissue (WAT). Here we explore whether PPARα activation potentiates the effect of β3-adrenergic stimulation on energy balance mediated by the respective agonists OEA and CL316243. The effect of this pharmacological association on feeding, thermogenesis, β-oxidation, and lipid and cholesterol metabolism in epididymal (e)WAT was monitored. CL316243 (1 mg/kg) and OEA (5 mg/kg) co-administration over 6 days enhanced the reduction of both food intake and body weight gain, increased the energy expenditure and reduced the respiratory quotient (VCO2/VO2). This negative energy balance agreed with decreased fat mass and increased BAT weight and temperature, as well as with lowered plasma levels of triglycerides, cholesterol, nonessential fatty acids (NEFAs), and the adipokines leptin and TNF-α. Regarding eWAT, CL316243 and OEA treatment elevated levels of the thermogenic factors PPARα and UCP1, reduced p38-MAPK phosphorylation, and promoted brown-like features in the white adipocytes: the mitochondrial (Cox4i1, Cox4i2) and BAT (Fgf21, Prdm16) genes were overexpressed in eWAT. The enhancement of the fatty-acid β-oxidation factors Cpt1b and Acox1 in eWAT was accompanied by an upregulation of de novo lipogenesis and reduced expression of the unsaturated-fatty-acid-synthesis enzyme gene, Scd1. We propose that the combination of β-adrenergic and PPARα receptor agonists promotes therapeutic adipocyte remodelling in eWAT, and therefore has a potential clinical utility in the treatment of obesity.

4 April 2012 in Journal of Neuroendocrinology
Verified
Journal Article
Closed access
PDF file
SRSilvana Yanina Romero-Zerbo
Silvana Yanina Romero-Zerbo
MGM. S. Garcia‐Gutierrez
M. S. Garcia‐Gutierrez
JSJ. Suárez
J. Suárez
PRPatricia Rivera
Patricia Rivera
IRInmaculada Ruz-Maldonado
Inmaculada Ruz-Maldonado
FBFrancisco J Bermudez-Silva
Francisco J Bermudez-Silva

1 September 2009 in Journal of Neuropathology & Experimental Neurology
Verified
Journal Article
Closed access
PDF file
AJAntonio J Jiménez
Antonio J Jiménez
JGJose Manuel García-Verdugo
Jose Manuel García-Verdugo
CGCésar Aliro González
César Aliro González
LBLuis Federico Batiz
Luis Federico Batiz
LRLuis Manuel Rodríguez-Pérez
Luis Manuel Rodríguez-Pérez
JPJosé Manuel Pérez-Fígares
José Manuel Pérez-Fígares
Neural stem cells persist after embryonic development in the subventricular zone (SVZ) niche and produce new neural cells during postnatal life; ependymal cells are a key component associated with this neurogenic niche. In the animal model of human hydrocephalus, the hyh mouse, the ependyma of the lateral ventricles is progressively lost during late embryonic and early postnatal life and disappears from most of the ventricular surface throughout its life span. To determine the potential consequences of this loss on the SVZ, we characterized the abnormalities in this neurogenic niche in hyh mice. There was overall disorganization and a marked reduction of proliferative cells in the SVZ of both newborn and adult hyh hydrocephalic mice in vivo; neuroblasts were displaced to the ventricular surface, and their migration through the rostral migratory stream was reduced. The numbers of resident neural progenitor cells in hyh mice were also markedly reduced, but they were capable of proliferating, forming neurospheres, and differentiating into neurons and glia in vitro in a manner indistinguishable from that of wild-type progenitor cells. These findings suggest that the reduction of proliferative activity observed in vivo is not caused by a cell autonomous defect of SVZ progenitors but is a consequence of a reduced number of these cells. Furthermore, the overall tissue disorganization of the SVZ and displacement of neuroblasts imply alterations in the neurogenic niche of postnatal hyh mice.